Literature DB >> 3040001

Mechanism of inhibition of herpes simplex virus replication by delta 7-prostaglandin A1 and delta 12-prostaglandin J2.

N Yamamoto, M Fukushima, T Tsurumi, K Maeno, Y Nishiyama.   

Abstract

We studied the effect of prostaglandins (PGs) A1, delta 7-A1, A2, D2, E1, E2, F2 alpha, J2 and delta 12-J2 on the replication of herpes simplex virus type 2 (HSV-2). Of nine PGs we tested, delta 7-PGA1 was found to have the most potent inhibitory effect; 50% inhibitory dose (ID50) was 0.35 microgram/ml in the plaque reduction assays and HSV-2 induced protein synthesis was strongly suppressed at 0.5 microgram/ml whereas at this dose, the protein synthesis of uninfected cells was not inhibited. Dot blot hybridization analysis revealed that delta 7-PGA1 and delta 12-PGJ2 inhibited the primary transcription of HSV-2. Thus we suggest that those PGs are primarily active at the level of mRNA synthesis.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3040001     DOI: 10.1016/0006-291x(87)90809-6

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  9 in total

1.  Assessment of antiviral activity, efficacy, and toxicity of prostaglandin A2 in a rabbit model of herpetic keratitis.

Authors:  W J O'Brien; J L Taylor; H Ankel; G Sitenga
Journal:  Antimicrob Agents Chemother       Date:  1996-10       Impact factor: 5.191

2.  Role of DNA topoisomerase I in the replication of herpes simplex virus type 2.

Authors:  Y Yamada; N Yamamoto; K Maeno; Y Nishiyama
Journal:  Arch Virol       Date:  1990       Impact factor: 2.574

3.  Delta(12)-prostaglandin J(2) is a potent inhibitor of influenza A virus replication.

Authors:  F Pica; A T Palamara; A Rossi; A De Marco; C Amici; M G Santoro
Journal:  Antimicrob Agents Chemother       Date:  2000-01       Impact factor: 5.191

4.  Effects of dimethyl prostaglandin A1 on herpes simplex virus and human immunodeficiency virus replication.

Authors:  M Hughes-Fulford; M S McGrath; D Hanks; S Erickson; L Pulliam
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

5.  Inhibition of poliovirus replication by prostaglandins A and J in human cells.

Authors:  C Conti; P Mastromarino; P Tomao; A De Marco; F Pica; M G Santoro
Journal:  Antimicrob Agents Chemother       Date:  1996-02       Impact factor: 5.191

6.  Inhibition of HIV-1 replication by cyclopentenone prostaglandins in acutely infected human cells. Evidence for a transcriptional block.

Authors:  C Rozera; A Carattoli; A De Marco; C Amici; C Giorgi; M G Santoro
Journal:  J Clin Invest       Date:  1996-04-15       Impact factor: 14.808

7.  Selective inhibition of virus protein synthesis by prostaglandin A1: a translational block associated with HSP70 synthesis.

Authors:  C Amici; C Giorgi; A Rossi; M G Santoro
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

Review 8.  Immuno-pathogenesis of nCOVID-19 and a possible host-directed therapy including anti-inflammatory and anti-viral prostaglandin (PG J2) for effective treatment and reduction in the death toll.

Authors:  Shakeel Shahzad; Mark Willcox
Journal:  Med Hypotheses       Date:  2020-07-08       Impact factor: 1.538

Review 9.  Cyclopentenone Prostaglandins: Biologically Active Lipid Mediators Targeting Inflammation.

Authors:  Bohae Rachel Lee; May Hnin Paing; Neelam Sharma-Walia
Journal:  Front Physiol       Date:  2021-07-15       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.